Contribute Try STAT+ Today

Amid a push to encourage companies and universities to register and report clinical trials in the U.K., the chair of an influential Parliamentary committee is renewing his call for violators to be sanctioned, echoing a plea made last week by a dozen patient advocacy groups.

Norman Lamb, whose Science and Technology Committee last October issued a blistering report criticizing the lack of clinical trial transparency, again urged the U.K.’s Health Research Authority to enforce rules and impose penalties on companies on wayward trial sponsors and investigators.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Your daily dose of news in health and medicine

Privacy Policy